Creo Medical Group PLC
LSE:CREO
Creo Medical Group PLC
Revenue
Creo Medical Group PLC
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Creo Medical Group PLC
LSE:CREO
|
Revenue
£27.2m
|
CAGR 3-Years
1 163%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Smith & Nephew PLC
LSE:SN
|
Revenue
$5.5B
|
CAGR 3-Years
7%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
LivaNova PLC
NASDAQ:LIVN
|
Revenue
$1.2B
|
CAGR 3-Years
7%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Revenue
$254.5m
|
CAGR 3-Years
123%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Revenue
£52.6m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
5%
|
|
Angle PLC
LSE:AGL
|
Revenue
£1.8m
|
CAGR 3-Years
31%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Creo Medical Group PLC's Revenue?
Revenue
27.2m
GBP
Based on the financial report for Dec 31, 2022, Creo Medical Group PLC's Revenue amounts to 27.2m GBP.
What is Creo Medical Group PLC's Revenue growth rate?
Revenue CAGR 3Y
1 163%
Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Creo Medical Group PLC have been 1 163% over the past three years .